메뉴 건너뛰기




Volumn 156, Issue 8, 1999, Pages 1270-1272

Clozapine-associated elevation in serum triglycerides

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CLOZAPINE; HALOPERIDOL; TRIACYLGLYCEROL;

EID: 0032838889     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (134)

References (8)
  • 1
    • 0023812652 scopus 로고
    • Clozapine for the treatment-resistant schizophrenic: A double-blind comparison with chlorpromazine
    • Kane J, Honigfeld G, Singer J, Meltzer H: Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988; 45: 789-796
    • (1988) Arch Gen Psychiatry , vol.45 , pp. 789-796
    • Kane, J.1    Honigfeld, G.2    Singer, J.3    Meltzer, H.4
  • 2
    • 0028072038 scopus 로고
    • Agranulocytosis: Incidence and risk factors
    • Alvir JMJ, Lieberman JA: Agranulocytosis: incidence and risk factors. J Clin Psychiatry 1994; 55:137-138
    • (1994) J Clin Psychiatry , vol.55 , pp. 137-138
    • Alvir, J.M.J.1    Lieberman, J.A.2
  • 3
    • 0026836705 scopus 로고
    • Clinical profile of clozapine: Adverse reactions and agranulocytosis
    • Lieberman JA, Safferman AZ: Clinical profile of clozapine: adverse reactions and agranulocytosis. Psychiatr Q 1992; 63: 51-70
    • (1992) Psychiatr Q , vol.63 , pp. 51-70
    • Lieberman, J.A.1    Safferman, A.Z.2
  • 5
    • 0000082475 scopus 로고
    • Elevated serum triglycerides on clozapine resolve with risperidone
    • Ghaeli P, Dufresne RL: Elevated serum triglycerides on clozapine resolve with risperidone (abstract). Pharmacotherapy 1995; 15:382
    • (1995) Pharmacotherapy , vol.15 , pp. 382
    • Ghaeli, P.1    Dufresne, R.L.2
  • 6
    • 0029780507 scopus 로고    scopus 로고
    • Serum triglyceride levels in patients treated with clozapine
    • Ghaeli P, Dufresne RL: Serum triglyceride levels in patients treated with clozapine. Am J Health Syst Pharm 1996; 53: 2079-2081
    • (1996) Am J Health Syst Pharm , vol.53 , pp. 2079-2081
    • Ghaeli, P.1    Dufresne, R.L.2
  • 7
    • 0031846072 scopus 로고    scopus 로고
    • Diminished suicidal and aggressive behavior, high plasma norepinephrine levels, and serum triglyceride levels in chronic neuroleptic-resistant schizophrenic patients maintained on clozapine
    • Spivak B, Roitman S, Vered Y, Mester R, Graff E, Talmon Y, Guy N, Gonen N, Weizman A: Diminished suicidal and aggressive behavior, high plasma norepinephrine levels, and serum triglyceride levels in chronic neuroleptic-resistant schizophrenic patients maintained on clozapine. Clin Neuropharmacol 1998; 21:245-250
    • (1998) Clin Neuropharmacol , vol.21 , pp. 245-250
    • Spivak, B.1    Roitman, S.2    Vered, Y.3    Mester, R.4    Graff, E.5    Talmon, Y.6    Guy, N.7    Gonen, N.8    Weizman, A.9
  • 8
    • 0344943727 scopus 로고
    • Lipid disorders
    • Edited by Woodley M, Whelan A. Boston, Little, Brown
    • Goldberg AC: Lipid disorders, in Manual of Medical Therapeutics, 27th ed. Edited by Woodley M, Whelan A. Boston, Little, Brown, 1993, pp 419-424
    • (1993) Manual of Medical Therapeutics, 27th Ed. , pp. 419-424
    • Goldberg, A.C.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.